latest news releases from the newsroom
VSUS Technologies, Inc.
VSUS Technologies, Incorporated Retains Newport Capital Consultants, Inc. for IR and Consulting Services
BOCA RATON, Fla., July 18, 2005 (PRIMEZONE) -- VSUS Technologies, Incorporated (OTCBB:VSUS) announces today that they have retained Newport Capital Consultants, Inc. to assist the company with IR and consulting related services. Based in Laguna Niguel, California, Newport Capital Consultants, Inc. is a full-service financial consulting firm that's focus is to expand awareness for select private and publicly held companies from within the domestic and international financial communities. Mr. Gary Bryant, the President of Newport Capital Consultants commented, "We are thrilled to be engaged by VSUS Technologies. The company is solid in every aspect from management down to the products they offer and we are proud to be a member of the team. We look forward to assisting the company with upcoming road shows and conferences."
Golden Ocean Group Limited
Golden Ocean Group Limited -- Private Placement
Hamilton, Norway, July 18, 2005 (PRIMEZONE) -- The Board of Golden Ocean Group Limited is pleased to announce that the Company has completed a private placement of 22,400,000 shares placed at a subscription price of NOK 4.23 per share. The proceeds from the offering, approximately USD 14 million, will mainly be used to finance the equity portion for the recently delivered Panamax Golden Dena.
Trintech Group Plc
Midas, Inc. Selects Trintech's ReconNET for Cash Reconciliation and Improved Operational Control
DALLAS and DUBLIN, Ireland, July 18, 2005 (PRIMEZONE) -- Trintech (Nasdaq:TTPA), a leading provider of transaction reconciliation and payment infrastructure solutions, today announced that Midas, Inc. (NYSE:MDS), has selected ReconNET for use in their Company Operated Shops to automate the verification and reconciliation of cash, credit card transactions, and purchase cards, which are used by stores to buy parts from third party suppliers. The installation of ReconNET is enabling the company to improve daily productivity, reduce write-offs, and increase daily visibility into cash balances.
MorphoSys Strengthens Pre-clinical Development and Finance Departments in New Management Positions
MARTINSRIED, Germany, July 18, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment, TecDAX) announced today that it has strengthened its management in two positions by appointing Dr. Robert Friesen as Director of Pre-Clinical Development and Dr. Bernhard Erning as Director of Treasury & Corporate Development. Dr. Friesen will coordinate the further development of the Company's proprietary, therapeutic antibody programs and head their strategic management. Dr. Erning will be responsible for the areas of Treasury, Corporate Development and Financial Instruments.